PHARMACEUTICAL FORMULATION FOR USE IN HIV THERAPY

摘要

A monolithic tablet formulation comprising: a) a nucleotide analog reverse transcriptase inhibitor (NtRTI); b) a non-nucleoside reverse transcriptase inhibitors (NNRTI); c) a nucleoside analog reverse transcriptase inhibitors (NRTI) and d) one or more pharmaceutically acceptable carriers or excipients. Also disclosed is another pharmaceutical formulation comprising: a) nucleotide analog reverse transcriptase inhibitors (NtRTIs); b) nucleoside analog reverse transcriptase inhibitors (NRTIs) and d) one or more pharmaceutically acceptable carriers or excipients.